Jainambu Beevi S.1*, Sarumushrashri A.2, Asiha Fathima M.2, Vasanthapriya S.2, Sethuram S.2, Esther Subitha C.2

VERNAKALANT HYDROCHLORIDE FOR THE RAPID CONVERSION OF RECENT-ONSET ATRIAL FIBRILLANTION: PHARMACOLOGY, CLINICAL EFFICACY, AND SAFETY

Background: Atrial fibrillation is a common arrhythmia associated with stroke risk. Vernakalant hydrochloride is an intravenous, atrial-selective antiarrhythmic developed for the rapid conversion of recent-onset AF, offering an alternative to amiodarone, which may cause systemic...

VERNAKALANT HYDROCHLORIDE FOR THE RAPID CONVERSION OF RECENT-ONSET ATRIAL FIBRILLANTION: PHARMACOLOGY, CLINICAL EFFICACY, AND SAFETY

Background: Atrial fibrillation is a common arrhythmia associated with stroke risk. Vernakalant hydrochloride is an intravenous, atrial-selective antiarrhythmic developed for the rapid conversion of recent-onset AF, offering an alternative to amiodarone, which may cause systemic...